NCT02341521View on ClinicalTrials.gov

Evaluation of Metabolic Profile of OC000459

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Asthma
Interventions
DRUG

OC000459

Taken orally for 8 days

Trial Locations (1)

CF48 4DR

Simbec Research, Merthyr Tydfil

Sponsors
All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

lead

Atopix Therapeutics, Ltd.

INDUSTRY

NCT02341521 - Evaluation of Metabolic Profile of OC000459 | Biotech Hunter | Biotech Hunter